Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview.

Reva S, Nosov A, Novikov R, Petrov S.

Int Sch Res Notices. 2014 Jul 15;2014:243080. doi: 10.1155/2014/243080. eCollection 2014. Review.

2.

PET/MRI in Oncological Imaging: State of the Art.

Bashir U, Mallia A, Stirling J, Joemon J, MacKewn J, Charles-Edwards G, Goh V, Cook GJ.

Diagnostics (Basel). 2015 Jul 21;5(3):333-57. doi: 10.3390/diagnostics5030333. Review.

3.

Role of multiparametric magnetic resonance imaging in early detection of prostate cancer.

De Visschere PJ, Briganti A, Fütterer JJ, Ghadjar P, Isbarn H, Massard C, Ost P, Sooriakumaran P, Surcel CI, Valerio M, van den Bergh RC, Ploussard G, Giannarini G, Villeirs GM.

Insights Imaging. 2016 Apr;7(2):205-14. doi: 10.1007/s13244-016-0466-9. Epub 2016 Feb 4. Review.

4.

Prostate MRSI predicts outcome in radical prostatectomy patients.

Zakian KL, Hatfield W, Aras O, Cao K, Yakar D, Goldman DA, Moskowitz CS, Shukla-Dave A, Tehrani YM, Fine S, Eastham J, Hricak H.

Magn Reson Imaging. 2016 Jun;34(5):674-81. doi: 10.1016/j.mri.2016.01.003. Epub 2016 Jan 26.

PMID:
26821278
5.

Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?

García-Figueiras R, Baleato-González S, Padhani AR, Oleaga L, Vilanova JC, Luna A, Cobas Gómez JC.

Diagn Interv Radiol. 2016 Jan-Feb;22(1):75-89. doi: 10.5152/dir.2015.15009.

6.

The role of MRI in prostate cancer active surveillance.

Johnson LM, Choyke PL, Figg WD, Turkbey B.

Biomed Res Int. 2014;2014:203906. doi: 10.1155/2014/203906. Epub 2014 Nov 30. Review.

7.

Radical prostatectomy specimens - a voice against focal therapy.

Adamczyk P, Tworkiewicz J, Drewa T.

Cent European J Urol. 2014;67(3):235-41. doi: 10.5173/ceju.2014.03.art5. Epub 2014 Aug 18.

8.

Functional MRI in prostate cancer detection.

Sankineni S, Osman M, Choyke PL.

Biomed Res Int. 2014;2014:590638. doi: 10.1155/2014/590638. Epub 2014 Jul 23. Review.

9.

Imaging and intervention in prostate cancer: Current perspectives and future trends.

Sharma S.

Indian J Radiol Imaging. 2014 Apr;24(2):139-48. doi: 10.4103/0971-3026.134399.

10.

Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging.

Matulewicz L, Jansen JF, Bokacheva L, Vargas HA, Akin O, Fine SW, Shukla-Dave A, Eastham JA, Hricak H, Koutcher JA, Zakian KL.

J Magn Reson Imaging. 2014 Dec;40(6):1414-21. doi: 10.1002/jmri.24487. Epub 2013 Nov 15.

11.

The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.

Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M.

BJU Int. 2014 Feb;113(2):218-27. doi: 10.1111/bju.12243. Epub 2013 Nov 13.

12.

The role of metabolic imaging in radiation therapy of prostate cancer.

Zhang VY, Westphalen A, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J.

NMR Biomed. 2014 Jan;27(1):100-11. doi: 10.1002/nbm.3007. Epub 2013 Aug 12. Review.

13.

Performance of multiparametric magnetic resonance imaging in the evaluation and management of clinically low-risk prostate cancer.

Dianat SS, Carter HB, Macura KJ.

Urol Oncol. 2014 Jan;32(1):39.e1-10. doi: 10.1016/j.urolonc.2013.04.002. Epub 2013 Jun 17. Review.

14.

Focal therapy for prostate cancer: rationale and treatment opportunities.

Kasivisvanathan V, Emberton M, Ahmed HU.

Clin Oncol (R Coll Radiol). 2013 Aug;25(8):461-73. doi: 10.1016/j.clon.2013.05.002. Epub 2013 Jun 4. Review.

15.

Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.

Giskeødegård GF, Bertilsson H, Selnæs KM, Wright AJ, Bathen TF, Viset T, Halgunset J, Angelsen A, Gribbestad IS, Tessem MB.

PLoS One. 2013 Apr 23;8(4):e62375. doi: 10.1371/journal.pone.0062375. Print 2013.

16.

Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.

Hegde JV, Mulkern RV, Panych LP, Fennessy FM, Fedorov A, Maier SE, Tempany CM.

J Magn Reson Imaging. 2013 May;37(5):1035-54. doi: 10.1002/jmri.23860. Review.

17.

Magnetic resonance imaging for prostate cancer clinical application.

Li B, Du Y, Yang H, Huang Y, Meng J, Xiao D.

Chin J Cancer Res. 2013 Apr;25(2):240-9. doi: 10.3978/j.issn.1000-9604.2013.03.06.

18.

Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry.

Spur EM, Decelle EA, Cheng LL.

Eur J Nucl Med Mol Imaging. 2013 Jul;40 Suppl 1:S60-71. doi: 10.1007/s00259-013-2379-x. Epub 2013 Apr 3. Review.

19.

Multi-kernel graph embedding for detection, Gleason grading of prostate cancer via MRI/MRS.

Tiwari P, Kurhanewicz J, Madabhushi A.

Med Image Anal. 2013 Feb;17(2):219-35. doi: 10.1016/j.media.2012.10.004. Epub 2012 Dec 13.

20.

Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.

Vargas HA, Akin O, Shukla-Dave A, Zhang J, Zakian KL, Zheng J, Kanao K, Goldman DA, Moskowitz CS, Reuter VE, Eastham JA, Scardino PT, Hricak H.

Radiology. 2012 Nov;265(2):478-87. doi: 10.1148/radiol.12120041. Epub 2012 Sep 5.

Items per page

Supplemental Content

Write to the Help Desk